The PiezoWave from Richard Wolf combines orthopaedic ESWT applications with the applications of TPST. Extracorporeal shock waves have been used successfully in the treatment of chronic pain since the early '90s. Extracorporeal shock wave therapy (ESWT) and trigger point shock wave therapy (TPST) are highly efficient, non-surgical treatments for chronic pain in the musculoskeletal system. The PiezoWave offers a significant expansion of the range of applications for myofascial pain syndrome. The extracorporeal, focused shock wave allows precise diagnosis and therapy of active and latent trigger points. Trigger points are thickened, pain-sensitive points within a usually tense muscle. They can cause a variety of pains – even well away from their own location. 

How it works

The heart of the Richard Wolf PiezoWave is the compact piezo shock-wave source with its outstanding characteristics. Simple to operate. All the device parameters can be set and monitored with precision. At the therapy source, the depth of penetration can be varied by using gel pads of different thicknesses.  A further advantage is the large-area energy coupling with an aperture angle of 94°. This lowers the energy density at the surface of the skin and reduces pain. 20 Intensity levels allow finely adjusted application of energy and treatment without sedation.

By using gel pads of different thicknesses, the depth of penetration can be adjusted allowing precise treatment of different trigger points and regions.